Skip to main content
Download PDF

Prevalence of depression among people living with HIV in rural hospitals in South-Western Nigeria-Association with clinico-demographic factors

AIDS Research and Therapy volume 20, Article number: 89 (2023) Cite this article

Abstract

Major depression is the most common neuropsychiatric disorder among people living with HIV (PLWH) and is predictive of high morbidity and mortality among them. This study estimated the prevalence and explored factors associated with depression among PLWH in two rural secondary health facilities providing anti-retroviral therapy (ART) services in Southwestern Nigeria between September and December 2020. The Patient Health Questionnaire-9 (PHQ-9) was used to screen and identify PLWH aged 18 years or older with depression. Descriptive statistics, bivariate and multivariate analyses were performed with SPSS version 23. A total of 172 respondents were screened. The prevalence of depression was 16.3% (95% CI 11.1%, 22.7%). Mild, moderate, and moderately severe depression was identified in 17 (9.9%), 8(4.7%) and 3(1.7%) of the participants, respectively. One (0.6%) respondent had suicidal ideation. Of PLWH with any depression, 20/28(71.4%) were within the 40–59 years of age range. None of the participants was on antidepressants. The factor most associated with depression was hypertension, with adjusted odd ratios of 9.8(95% CI 3.5–27.3, p < 0.0001). The study highlights the importance of screening for the severity of depression among PLWH in rural hospitals providing ART services in Africa. PLWH with comorbid hypertension were more likely to suffer from some form of depression.

Introduction

Globally, there has been a positive change in the demographics of people living with HIV (PLWH) in the last three decades due to the availability and effectiveness of anti-retroviral therapy (ART) [1]. PLWH are faced with a paradigm change from a disease with high morbidity and mortality, mainly from infectious diseases to a more significant burden of non-communicable diseases [2, 3].

Depression is the most common neuropsychiatric disorder among PLWH. Depression results in poor physical health [4], reduced ART adherence [5,6,7], treatment failure [8], reduced quality of life [9, 10], increased suicidal behaviours [11, 12] and HIV-related mortality among PLWH [13].

The risk of depression is higher among PLWH when compared with the general population. For example, a study in the United States (US) reported a prevalence of 58% elevated depressive scores among PLWH compared to 33% among HIV seronegative individuals [14].

Globally, the prevalence of depression among PLWH ranges from 28 to 34%, with a higher prevalence in low- and middle-income countries in contrast to developed countries [15]. The prevalence of depression among PLWH is 22 to 32% in the US [16, 17], 43.0% in China [18], 29.3–47.5% in East Africa [19], 9 to 32% in sub-Saharan Africa [20], and 23–28% in Nigeria [21, 22]. However, despite the high burden of depression among PLWH, it remains a neglected public health problem in sub-Saharan Africa [20].

In Africa, there are disparities in the access to health care and availability of specialised services, including mental health care, in rural areas. It is unknown whether the prevalence of depression is similar between PLWH living in rural and urban areas in sub-Saharan Africa. This study determined the prevalence and explored factors associated with major depression among PLWH in two rural state hospitals providing ART services in Southwestern Nigeria.

Methods

Study design

This was a descriptive cross-sectional study.

Setting

This study was conducted at the State Hospital Saki and General Hospital Okeho in the Oke-Ogun Region of Oyo State, Southwest Nigeria. Oke-Ogun is in the Oyo-North senatorial district, a rural community with poor socioeconomic indices. Most inhabitants are Yoruba; other ethnic groups like Igbo, Hausa, and Fulani constitute minority populations. Some foreigners like the Beninese and Togolese also reside in the region.

Secondary healthcare facilities are present in most of the region’s major towns, with six health facilities offering ART services. Both hospitals selected have similar characteristics, including the demographics of the PLWH receiving ART services in the hospitals.

Participants

The target population comprises PLWH accessing HIV care and support services at the ART clinics. The inclusion criteria included consenting male or female PLWH aged 18 years and above, residents of the Okeogun area and accessing outpatient HIV care and support services at the selected ART clinics.

Data collection

A semi-structured questionnaire was adapted from previous studies [22,23,24,25]. The interviewer-administered questionnaire included sections incorporating the sociodemographic characteristics, PHQ-9, and clinical information, which were retrieved from the participants’ case notes. Participants were screened for depression using PHQ-9. This tool has been validated and used in sub-Saharan Africa [25,26,27]. The final PHQ-9 score was graded to determine the presence (PHQ9 ≥ 5) or absence of a depression (PHQ9 < 5) and its severity as mild depression (5–9), moderate depression (10–14), moderately severe depression (15–19), and severe depression (20–27). The questionnaire was translated into the local language (Yoruba). Trained research assistants administered the questionnaires in local language under the supervision of the principal investigator. A consecutive visit-based sampling technique was used based on clinic attendance. The study was conducted between September and November 2020.

Statistical analysis

The data obtained were cleaned and entered into SPSS version 23. The sociodemographic characteristics were summarised with descriptive statistics (frequency and proportions) and presented as text and table. The inter-rater reliability, Cohen’s Kappa was 0.69. The quantitative variables were summarised with a mean (standard deviation) or median (interquartile range) if not normally distributed. Chi-square test, odds ratios (ORs) and 95% confidence intervals (CIs) were used to characterise factors associated with depression among PLWH. Fisher’s exact test was used for small cell counts. Binary outcomes were examined in a univariate and multivariate fashion using logistic regression. The level of significance was set at 5%.

Results

Sociodemographic and clinical characteristics of the participants

Of the 230 participants approached, 172 (75%) completed the questionnaires and were screened for depression (Fig. 1). There were no characteristic differences between those that refused participation and those included in the study. Of the participants, 94 (54.7%) were aged 40–59 years, 128 (74.4%) were females, and 138 (80.2%) were married. Table 1 shows other sociodemographic characteristics of the participants. The mean age (standard deviation) of the participants was 44.3 ± 11.7 years. The median (interquartile range) monthly income was 15,000 naira (15,000). The median (interquartile range) duration of ART was 4.5 (7.5 years), and the viral load was 39.8 (287.5) copies per millilitre. About three-quarters of the participants on ART had viral suppression (HIV viral loads < 200 copies per millilitres). The median (interquartile range) of the latest CD4 count was 520 (335) cells/mm3. The prevalence of hypertension among the participants was 14%, and only one (0.6%) participant had suicidal ideations, gestures, or attempts.

Prevalence of major depression among PLWH

The prevalence of depression (95% CI) was 16.3% (11.1%, 22.7%) overall, with 17.2% (11.1%, 24.9%) in females and 13.6% (5.2%, 27.4%) in males. No statistically significant difference between the difference in the proportion of depression prevalence between males and females (OR 0.761; 95% CI 0.287–2.019, p = 0.582). Among the 28 participants with depressive disorders, 17 (9.9%) presented with mild depression, 8 (4.7%) had moderate depression, and 3 (1.7%) had moderately severe depression. Most of the participants with depression, 20/28 (71.4%), were within the 40–59 years age range.

Factors associated with depression among PLWH

In the bivariate analysis (Table 2), the following factors were significantly associated with depression: hypertension (OR 10.5; 95% CI 4–27.5, p < 0.0001) and efavirenz use (OR 1.22; 95% CI 1.14–1.32, p = 0.042). However, after multivariate analysis, the only factor associated with depression among PLWH was hypertension (AOR 9.8; 95% CI 3.5–27.3, p < 0.0001).

Fig. 1
figure 1

Flow diagram of recruitment of study participants

Full size image
Table 1 Sociodemographic characteristics of 172 PLWH in two rural secondary health facilities, Southwest, Nigeria, 2020
Full size table
Table 2 Factors associated with depression among 172 PLWH in two rural secondary health facilities, Southwest, Nigeria, 2020
Full size table

Discussion

Depression is a non-communicable disease of global public health importance among PLWH [28]. This study determined the prevalence and explored factors associated with depression among PLWH in rural secondary health facilities providing ART services in Southwestern Nigeria. The prevalence of major depression among PLWH on ART was 16.3%. This finding is lower than that of other studies done in Africa in different places, Northern Tanzania, 20.9% [29], Ethiopia, 35.8% [30], Cameroon, 26.7% [31] and 30.4% in a recent systematic review and meta-analysis of non-communicable diseases burden among PLWH in sub-Saharan Africa [32]. However, our finding is similar to a systematic review and meta-analysis that reported the overall prevalence of major depression among PLWH in Sub-Saharan Africa using a diagnostic interview to be 15.3% [33]. The difference in the findings may also be due to variations in sample size, the study population (rural versus urban), the study period, the eligibility criteria and survey instruments used to assess depression. Most of these studies were performed in urban areas and tertiary hospitals, while our study was conducted in secondary health facilities in rural areas.

The odds of major depression were higher among those on efavirenz-containing ART in bivariate analysis. However, few participants were on efavirenz-containing ART, as the favoured first-line ART in Nigeria is dolutegravir-containing ART. Efavirenz has psychotropic properties, and chronic use has been associated with depression [34, 35]. Also, studies have reported improving depression after discontinuing long-term efavirenz treatment [36]. Contrarily, a systematic review in South Africa among PLWH treated with efavirenz reported depression as generally mild [37]. However, in this study, the association between efavirenz and major depression was not sustained after multivariate analysis.

Interestingly, hypertension is a chronic illness associated with depression, even among the general population [38]. In this study, those with hypertension had increased odds of having major depression. Kinyanda et al. in Uganda reported an association between depression and hypertension [39]. It has also been reported as one of the most prevalent NCDs among PLWH [40]. Screening and treating hypertension and other chronic non-communicable diseases among PLWH may reduce the burden of depression and improve their quality of life.

Female gender is a known risk factor for depression among PLWH [41,42,43]. However, in this study, gender was not statistically significantly associated with depression among PLWH. A probable reason for our findings is our study’s rural location, as women have more social support than in urban areas. Studies in sub-Saharan Africa also reported similar findings [44,45,46].

Unlike other studies, age, average monthly income, gender, religion, educational level, viral suppression, alcohol intake and ART duration were not statistically significantly associated with depression. However, the discrepancy may result from the small sample size of this study, the location of study participants (mainly rural dwellers) and the study period. This study was conducted during the COVID-19 pandemic, with a decline in clinic attendance by PLWH due to the lockdown by the government and fear of infection with COVID-19 by the people. Stigma, side effects, social support, treatment adherence, domestic abuse, and the number of children are other important covariates and confounders not included in the analysis and are significant limitations. Another limitation is recall bias, with a consequent effect on the study’s internal validity. Other limitations included inadequate sample size for multivariate analysis, the non-probability sampling method, and the hospital-based nature of the survey, which limited its generalisation.

Conclusions

The study highlights the importance of depression screening among PLWH in rural hospitals providing ART services in Africa. PLWH with comorbid hypertension was associated with depression. There is a need to integrate mental health care into the ART services for PLWH in Sub-Saharan Africa.

Data availability

The data supporting this study’s findings are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.

References

  1. Smiley CL, Rebeiro PF, Cesar C, et al. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study. The Lancet HIV May. 2021;8(5):e266–73.

    Article  CAS  Google Scholar 

  2. Chang D, Esber AL, Dear NF, et al. Non-communicable Diseases by age strata in people living with and without HIV in four African countries. J Int AIDS Soc Sep. 2022;25(Suppl 4):e25985.

    Article  Google Scholar 

  3. Raubinger S, Lee FJ, Pinto AN. HIV: the changing paradigm. Intern Med J Apr. 2022;52(4):542–9.

    Article  Google Scholar 

  4. Sikkema KJ, Dennis AC, Watt MH, Choi KW, Yemeke TT, Joska JA. Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countries. Global Mental Health (Cambridge England) Jan 2015;2.

  5. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and Meta-analysis. Jaids-Journal of Acquired Immune Deficiency Syndromes Oct. 2011;58(2):181–7.

    Article  Google Scholar 

  6. Gebrezgabher BB, Kebede Y, Kindie M, Tetemke D, Abay M, Gelaw YA. Determinants to antiretroviral treatment non-adherence among adult HIV/AIDS patients in northern Ethiopia. AIDS Res Therapy. 2017;14:16.

    Article  Google Scholar 

  7. Necho M, Zenebe Y, Tiruneh C, Ayano G, Yimam B. The Global Landscape of the Burden of depressive Symptoms/Major Depression in individuals living with HIV/AIDs and its effect on antiretroviral medication adherence: an Umbrella Review. Front Psychiatry. 2022;13:814360.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chawana TD, Reid A, Bwakura T, Gavi S, Nhachi CF. Factors influencing treatment failure in HIV positive adult patients on first line antiretroviral therapy. Cent Afr J Med May-Aug. 2014;60(5–8):29–36.

    CAS  Google Scholar 

  9. Adewuya AO, Afolabi MO, Ola BA, et al. Relationship between depression and quality of life in persons with HIV Infection in Nigeria. Int J Psychiatry Med. 2008;38(1):43–51.

    Article  PubMed  Google Scholar 

  10. Wakawa IA, Said JM, Abba WM, Shehu S, Rabbebe IB, Beida O. The impact of comorbid clinical depression on the health-related quality of life of adults on highly active antiretroviral therapy in maiduguri, northeastern Nigeria. Indian J Psychol Med Oct. 2014;36(4):408–17.

    Article  Google Scholar 

  11. O’Donnell JK, Gaynes BN, Cole SR, et al. Ongoing life stressors and suicidal ideation among HIV-infected adults with depression. J Affect Disord Jan. 2016;15:190:322–8.

    Article  Google Scholar 

  12. Passos SM, Souza LD, Spessato BC. High prevalence of Suicide risk in people living with HIV: who is at higher risk? AIDS Care. 2014;26(11):1379–82.

    Article  PubMed  Google Scholar 

  13. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. Jama Mar. 2001;21(11):1466–74.

    Article  Google Scholar 

  14. Rooney AS, Moore RC, Paolillo EW, et al. Depression and aging with HIV: associations with health-related quality of life and positive psychological factors. J Affect Disord May. 2019;15:251:1–7.

    Google Scholar 

  15. Rezaei S, Ahmadi S, Rahmati J, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Supportive & Palliative care Dec. 2019;9(4):404–12.

    Google Scholar 

  16. Brown GR, Rundell JR, McManis SE, Kendall SN, Zachary R, Temoshok L. Prevalence of psychiatric disorders in early stages of HIV Infection. Psychosom Med Sep-Oct. 1992;54(5):588–601.

    Article  CAS  Google Scholar 

  17. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.

    Article  CAS  PubMed  Google Scholar 

  18. Cai S, Liu L, Wu X, Pan Y, Yu T, Ou H, Depression. Anxiety, psychological symptoms and health-related quality of life in people living with HIV. Patient Prefer Adherence. 2020;14:1533–40.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ayano G, Solomon M, Abraha M. A systematic review and meta-analysis of epidemiology of depression in people living with HIV in East Africa. BMC Psychiatry Aug. 2018;15(1):254.

    Article  Google Scholar 

  20. Bernard C, Dabis F, de Rekeneire N. Prevalence and factors associated with depression in people living with HIV in sub-saharan Africa: a systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0181960.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Egbe CO, Dakum PS, Ekong E, Kohrt BA, Minto JG, Ticao CJ. Depression, suicidality, and Alcohol Use Disorder among people living with HIV/AIDS in Nigeria. BMC Public Health Jun. 2017;02(1):542.

    Article  Google Scholar 

  22. Obadeji A, Ogunlesi AO, Adebowale TO. Prevalence and predictors of depression in people living with HIV/AIDS attending an outpatient clinic in Nigeria. Iran J Psychiatry Behav Sci. 2014;8(1):26.

    PubMed  PubMed Central  Google Scholar 

  23. Obadeji A, Oluwole LO, Dada MU, Ajiboye AS, Kumolalo BF, Solomon OA. Assessment of Depression in a primary care setting in Nigeria using the PHQ-9. J Family Med Prim Care Jan-Mar. 2015;4(1):30–4.

    Article  Google Scholar 

  24. Adeoti AO, Dada MU, Fadare JO. Prevalence of depression and anxiety disorders in people living with HIV/AIDS in a tertiary hospital in South Western Nigeria. Med Rep Case Stud. 2018;3(1):1–5.

    Google Scholar 

  25. Sule HM, Agaba PA, Ojoh RO, Agbir MT, Okonoda KM. Prevalence of depression and associated factors in HIV-positive adults attending an antiretroviral clinic in Jos, Nigeria. J Family Med Health Care. 2018;4(4):26–32.

    Google Scholar 

  26. Cholera R, Gaynes BN, Pence BW, et al. Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa. J Affect Disord. 2014;167:160–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Shittu RO, Issa BA, Olanrewaju GT, Mahmoud AO, Odeigah LO, Sule AG. Social determinants of Depression: Social Cohesion, negative life events, and Depression among people living with HIV/Aids in Nigeria, West Africa. Int J MCH AIDS. 2014;2(2):174–81.

    PubMed  PubMed Central  Google Scholar 

  28. Arseniou S, Arvaniti A, Samakouri M. HIV Infection and depression. Psychiatry and Clinical Neurosciences Feb. 2014;68(2):96–109.

    Article  Google Scholar 

  29. Dua D, Stubbs O, Urasa S, et al. The prevalence and outcomes of depression in older HIV-positive adults in Northern Tanzania: a longitudinal study. J Neurovirology Aug. 2023;29(4):425–39.

    Article  Google Scholar 

  30. Necho M, Belete A, Tsehay M. Depressive symptoms and their determinants in patients who are on antiretroviral therapy in the case of a low-income country, Ethiopia: a systematic review and meta-analysis. Int J Ment Health Syst Jan. 2021;6(1):3.

    Article  Google Scholar 

  31. Ngum PA, Fon PN, Ngu RC, Verla VS, Luma HN. Depression among HIV/AIDS patients on highly active antiretroviral therapy in the Southwest Regional hospitals of Cameroon: a cross-sectional study. Neurol Therapy Jun. 2017;6(1):103–14.

    Article  Google Scholar 

  32. Moyo-Chilufya M, Maluleke K, Kgarosi K, Muyoyeta M, Hongoro C, Musekiwa A. The burden of non-communicable Diseases among people living with HIV in Sub-saharan Africa: a systematic review and meta-analysis. EClinicalMedicine Nov. 2023;65:102255.

    Article  Google Scholar 

  33. Lofgren SM, Bond DJ, Nakasujja N, Boulware DR. Burden of Depression in Outpatient HIV-Infected adults in Sub-saharan Africa; systematic review and Meta-analysis. AIDS and Behavior Jun. 2020;24(6):1752–64.

    Article  CAS  Google Scholar 

  34. Zareifopoulos N, Lagadinou M, Karela A, et al. Efavirenz as a psychotropic drug. Eur Rev Med Pharmacol Sci Oct. 2020;24(20):10729–35.

    CAS  Google Scholar 

  35. Xiao J, Liu Y, Li B, Zhang L, Han J, Zhao H. Anxiety, depression, and sleep disturbances among people on long-term efavirenz-based treatment for HIV: a cross-sectional study in Beijing, China. BMC Psychiatry Nov. 2022;16(1):710.

    Article  Google Scholar 

  36. Mothapo KM, Schellekens A, van Crevel R, et al. Improvement of depression and anxiety after discontinuation of long- term Efavirenz Treatment. CNS Neurol Disord Drug Target. 2015;14(6):811–8.

    Article  CAS  Google Scholar 

  37. Gaida R, Truter I, Grobler C, Kotze T, Godman B. A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications. Expert Rev anti-infective Therapy. 2016;14(4):377–88.

    Article  CAS  PubMed  Google Scholar 

  38. Li Z, Li Y, Chen L, Chen P, Hu Y. Prevalence of Depression in patients with Hypertension: a systematic review and Meta-analysis. Med Aug. 2015;94(31):e1317.

    CAS  Google Scholar 

  39. Kinyanda E, Kuteesa M, Scholten F, Mugisha J, Baisley K, Seeley J. Risk of major depressive disorder among older persons living in HIV-endemic central and southwestern Uganda. AIDS Care. 2016;28(12):1516–21.

    Article  PubMed  Google Scholar 

  40. Smit M, Olney J, Ford NP, et al. The growing burden of noncommunicable Disease among persons living with HIV in Zimbabwe. AIDS (London England) Mar. 2018;27(6):773–82.

    Article  Google Scholar 

  41. Algoodkar S, Kidangazhiathmana A, Rejani PP, Shaji KS. Prevalence and factors associated with Depression among clinically stable people living with HIV/AIDS on antiretroviral therapy. Indian J Psychol Med Nov-Dec. 2017;39(6):789–93.

    Article  Google Scholar 

  42. Chibanda D, Cowan F, Gibson L, Weiss HA, Lund C. Prevalence and correlates of probable common mental disorders in a population with high prevalence of HIV in Zimbabwe. BMC Psychiatry Feb. 2016;29:16:55.

    Article  Google Scholar 

  43. Bayes-Marin I, Egea-Cortés L, Palacio-Vieira J, et al. Determinants of depressive symptoms in people living with HIV: findings from a population-based study with a gender perspective. Int J Environ Res Public Health. 2023;20(4):3687.

    Article  PubMed  PubMed Central  Google Scholar 

  44. van Coppenhagen B, Duvenage HS. Prevalence of depression in people living with HIV and AIDS at the Kalafong Provincial Tertiary Hospital Antiretroviral Clinic. South Afr J Psychiatry: SAJP : J Soc Psychiatrists South Afr. 2019;25:1175.

    Google Scholar 

  45. Asangbeh SL, Sobngwi JL, Ekali GL, Eyoum C, Msellati P. Predictors of depression among patients on art in a rural health district in North West Cameroon. AIDS Care. 2016;28(2):205–8.

    Article  PubMed  Google Scholar 

  46. Endeshaw M, Walson J, Rawlins S, et al. Stigma in Ethiopia: association with depressive symptoms in people with HIV. AIDS Care. 2014;26(8):935–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate the management and staff of State Hospital Saki and General Hospital Okeho for their support during the conduct of this study. “Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW011995. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding

Fogarty International Center of the National Institutes of Health under Award Number K43TW011995.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria

    Waheed Adeola Adedeji & Fatai Adewale Fehintola

  2. Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria

    Waheed Adeola Adedeji & Fatai Adewale Fehintola

  3. Center for Integrated Global Biomedical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA

    Qing Ma, Raymond Cha & Gene D. Morse

  4. Department of Medical Microbiology and Parasitology, University College Hospital, Ibadan, Nigeria

    Abiodun Muhammed Raji

  5. Department of Clinical Pharmacy, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria

    Olaniran Mudasiru Rasaki

  6. Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

    Alan Hutson

  7. Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Babafemi O. Taiwo

  8. Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA

    Man E. Charurat

  9. Department of Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria

    Oyindamola B. Yusuf

  10. Department of Psychiatry, University of Ibadan, Ibadan, Nigeria

    Oye Gureje

Authors
  1. Waheed Adeola Adedeji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qing Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abiodun Muhammed Raji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raymond Cha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olaniran Mudasiru Rasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alan Hutson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Babafemi O. Taiwo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Man E. Charurat
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Oyindamola B. Yusuf
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fatai Adewale Fehintola
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Oye Gureje
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gene D. Morse
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study’s conception and design. Material preparation, data collection and analysis were performed by WAA and supervised by FAF. WAA wrote the first draft of the manuscript, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Waheed Adeola Adedeji.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the University of Ibadan/University College Hospital Ethical Review Committee (UI/EC/22/0242). Permission to administer the questionnaires was obtained from the Heads of the Hospitals. Informed consent was obtained from the participants.

Consent for publication

All authors read and approved the final manuscript.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adedeji, W.A., Ma, Q., Raji, A.M. et al. Prevalence of depression among people living with HIV in rural hospitals in South-Western Nigeria-Association with clinico-demographic factors. AIDS Res Ther 20, 89 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12981-023-00586-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12981-023-00586-0

Keywords

AIDS Research and Therapy

ISSN: 1742-6405

Contact us